Novavax

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Novavax 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About NVAX

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. 

CEO
John C.s Jacobs
CEOJohn C.s Jacobs
Employees
749
Employees749
Headquarters
Gaithersburg, Maryland
HeadquartersGaithersburg, Maryland
Founded
1987
Founded1987
Employees
749
Employees749

NVAX Key Statistics

Market cap
1.34B
Market cap1.34B
Price-Earnings ratio
-5.29
Price-Earnings ratio-5.29
Dividend yield
Dividend yield
Average volume
3.42M
Average volume3.42M
High today
$8.17
High today$8.17
Low today
$7.95
Low today$7.95
Open price
$8.05
Open price$8.05
Volume
769.17K
Volume769.17K
52 Week high
$11.97
52 Week high$11.97
52 Week low
$6.20
52 Week low$6.20

Stock Snapshot

As of today, Novavax(NVAX) shares are valued at $8.14. The company's market cap stands at 1.34B, with a P/E ratio of -5.29.

During the trading session on 2026-08-17, Novavax(NVAX) shares reached a daily high of $8.17 and a low of $7.95. At a current price of $8.14, the stock is +2.4% higher than the low and still -0.4% under the high.

Trading activity shows a volume of 769.17K, compared to an average daily volume of 3.42M.

Over the past 52 weeks, Novavax(NVAX) stock has traded between a high of $11.97 and a low of $6.20.

Over the past 52 weeks, Novavax(NVAX) stock has traded between a high of $11.97 and a low of $6.20.

NVAX News

MarketWatch 3d
Novavax Inc. stock underperforms Friday when compared to competitors - MarketWatch

...

Novavax Inc. stock underperforms Friday when compared to competitors - MarketWatch
Simply Wall St 5d
How Novavax’s Earnings Slide and New Share Shelf Will Impact Investors

In August 2026, Novavax, Inc. reported that its second-quarter revenue fell to US$56.7 million from US$239.24 million a year earlier, swinging from net income o...

How Novavax’s Earnings Slide and New Share Shelf Will Impact Investors

Analyst ratings

50%

of 8 ratings
Buy
50%
Hold
12.5%
Sell
37.5%

People also own

Based on the portfolios of people who own NVAX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.